Anemia and iron deficiency in inflammatory bowel disease: An open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 9, 2013, Pages 1027-1032

  Befrits, Ragnar ^a   Wikman, Ola ^b   Blomquist, Lars ^a   Hjortswang, Henrik ^c   Hammarlund, Per ^d   Bajor, Antal ^e   Klintman, Daniel ^f   Blom, Håkan ^g  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d Angelholm Hospital   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g SUNDERBY HOSPITAL   (Sweden)

Author keywords

Anemia; Ferric carboxymaltose; Inflammatory bowel disease; Iron deficiency

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; HEMOGLOBIN; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; BODY TEMPERATURE; CROHN DISEASE; DRUG SAFETY; ENTERITIS; FEMALE; HUMAN; INFUSION RELATED REACTION; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; NAUSEA; OBSERVATIONAL STUDY; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; SIDE EFFECT; ULCERATIVE COLITIS;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; COLITIS, ULCERATIVE; CROHN DISEASE; ERYTHROCYTE INDICES; FEMALE; FERRIC COMPOUNDS; FERRITINS; GUIDELINE ADHERENCE; HEMATINICS; HEMOGLOBINS; HUMANS; IRON; MALE; MALTOSE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; QUALITY OF LIFE; SWEDEN; TRANSFERRIN; YOUNG ADULT;

EID: 84883021296     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.819442     Document Type: Article

References (19)

1. Kulnigg S, Gasche C. Systematic review: Managing anemia in Crohn's disease. Aliment Pharmacol Ther 2006;24:1507-23 (Pubitemid 44915199)
2. Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol 2011;46:304-9
3. Sjöberg D, Nielsen I MLTH, Rönnblom A. Anemia in a population based IBD cohort; still high prevalence after one year (poster 414). J Crohn's Colitis 2012;6:s174-5
4. Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007;13:1545-53
5. Weiss G, Goodnough LT. Anemia of chronic disease. N Eng J Med 2005;352:1011-23
6. Skikne B, Punnonen K, Caldron P, Bennett M, Rehu M, Gasior G, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferring receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86:923-7
7. Van AG, Dignass A, Bokemeyer B. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: Special situations. J Crohn's Colitis 2013;7:1-33
8. Gisbert J, Bermejo F, Pajares R, Perez-Calle JL, Rodriques M, Algaba A, et al. Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement. Inflamm Bowel Dis 2009;15:1485-91
9. Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, Grännö C, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator- blind, multicentre study. Scand J Gastroenterol 2009;44:838-45
10. Erichsen K, Ulvik RJ, Nysaeter G, Johansson J, Ostberg J, Berstad A, et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005;40:1058-65 (Pubitemid 41291355)
11. Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzen H, Tysk C, Almer S, et al. The Short Health Scale: A valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol 2006;41:1196-203 (Pubitemid 44451683)
12. Stjernman H, Grännö C, Järnerot G, Ockander L, Tysk C, Blomberg B, et al. Short Health Scale: A valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflamm Bowel Dis 2008;14:47-52 (Pubitemid 351196868)
13. Stein J, Bager P, Befrits R, Danese S, Gasche C, Gudehus M, et al. Current practice of anemia management in patients with inflammatory bowel disease across nine European countries. 11th UEGW Congress, Stockholm; 2011; poster 0933
14. Kulnigg S, Stoinov S, Simanenkov V, Dudar L, Karnafel W, Garcia L, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: The ferric carboxymaltose (Ferinject-) randomized controlled trial. Am J Gastroenterol 2008;103:1182-92 (Pubitemid 351677967)
15. Evstatiev R, Marteau P, Iqbal T, Khalif I, Stein J, Bokemeyer B, et al. FERGIcor, a randomized controlled trial on Ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011;141: 846-53
16. Ganzoni AM. Intravenous iron-dextran: Therapeutic and experimental possibilities. Schweiz Med Wochenschr 1970; 100:301-3
17. Kulnigg S, Teischinger L, Dejaco C, Waldhör T, Gasche C. Rapid recurrence of IBD-Associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol 2009;104:1460-7
18. Evstatiev R, Alexeeva O, Bokemeyer B, Chopey I, Felder M, Gudehus M, et al. Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. Clinical Gastroenterology and Hepatology. 2013; in press
19. Wells C, Lewis S, Barton J, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006;12:123-30